"Liquid Brachytherapy," a novel technology for the treatment of inoperable tumors, jointly developed by ITG and The Gabriel Institute, has now been evaluated in 16 cases of canine osteosarcoma with very promising results. The latest treatment on "Juno," a 160 lb Saint Bernard was preformed at the new Texas A&M Institute for Preclinical Studies (TIPS). This was, in fact, the first clinical case treated at the new facility. TIPS brings state-of-the-art imaging capabilities to our efforts to move this technology forward. Juno's treatment was featured recently in MIT Technology Review and on KPTV in Portland, OR.
November 23, 2009
Sara
Barge presented McMillan Memorial Scholarship
Edna McMillan, Sara Barge, Keith Frank, Jim
Simon
Sara Barge, Biomedical Science major at Brazosport College, was
presented with the first annual Kenneth McMillan Memorial
Scholarship.
October 18, 2009
Veterinary Cancer Society - Austin,
TX
"Intralesional Liquid Brachytherapy in Dogs with
Appendicular Osteosarcoma"
Congratulations to Sara Barge, a
Biomedical Science major at Brazosport College. She is the first
recipient of the Kenneth McMillan Memorial Scholarship.
July 24, 2009
No Relationship with PharmaCom
BioVet
Due to many recent inquiries about a
relationship between ITG and PharmaCom BioVet Inc., ITG wishes to
state that we have no current relationship with this
company.
June 11, 2009
Kenneth McMillan Memorial
Scholarship
The Kenneth McMillan Memorial Scholarship is being initiated to
honor the memory of our late long-term friend and colleague
Kenneth McMillan. The scholarship will be
awarded annually to a deserving high school senior from the
Brazosport Independent School District. Kenneth had a long
career at The Dow Chemical Company, working along
side us for over twenty years. When we formed ITG,
Kenneth joined us and served as our Radiation Safety Officer and
Laboratory Director until his untimely passing in December of
2008.
Conference on the Application of Accelerators
in Research and Industry
"Liquid Brachytherapy - Direct Administration of Therapeutic
Isotopes into Tumors"
